A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors
Clinical trial NCT05593094 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05593094
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2027-08-31
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.